Meaney E

Language: English
References: 13
Page: 4-6
PDF size: 120.15 Kb.

ABSTRACT

A spectre is haunting the world: the spectre of the clinical guidelines (CG). It could be very difficult to estimate exactly how many CGs swarm the contemporary medical literature, but probably there are thousands of guides available worldwide expressing the opinion of numerous medical associations, consensus conferences, academic institutions and governmenthealth ministries, about almost every topic, wide or diminutive, of modern medicine. Usually, CGs are written by a panel of experts (self, governmental or peer appointed) who review systematically the attainable clinical data, weighing the statistic relevance of each piece of evidence, and finally producing a text aimed to support the bestscientific-based clinical care.

REFERENCES

1. Embree J. Writing clinical guidelines with evidence-based medicine. Can J Infect Dis. 2000; 11: 289-290.

2. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004; 328: 1490.

3. Feder G, Eccles M, Grol R, Griffiths C, Grimshaw J. Using clinical guidelines. BMJ. 1999; 318: 728-730.

4. Scalzitti DA. Evidence-based guidelines: application to clinical practice. Phys Ther. 2001; 81: 1622-1628.

5. Evidence-Based Medicine Working Group. Evidence based medicine. A new approach to teaching the practice of medicine. JAMA. 1992; 268: 2420-2425.

6. Greenhalgh T, Howick J,Maskrey N, Evidence Based Medicine Renaissance Group. Evidence based medicine: a movement in crisis? BMJ. 2014; 348: g3725.

7. Meaney A, Ceballos-Reyes G, Gutiérrez-Salmean G, Samaniego-Méndez V, Vela-Huerta A, Alcocer L et al. Cardiovascular risk factors in a Mexican middle-class urban population. The Lindavista Study. Baseline data. Arch Cardiol Mex. 2013; 83: 249-256.

8. Fanghänel-Salmón G, Gutiérrez-Salmeán G, Samaniego V, Meaney A, Sánchez-Reyes L, Navarrete U et al. Obesity phenotypes in urban middle-class cohorts. The PRIT-Lindavista merging evidence in Mexico: the OPUS-PROME study. Nutr Hosp. 2015; 32: 182-188.

9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Reportof the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation,and Treatment of High Blood Cholesterolin Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-2497.

10. Stone NJ, Robinson J, Lichtenstein AH, et al; 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 63: 2889-2934.

11. Estrada-García T, Meaney A, López-Hernández D, Meaney E, Sánchez-Hernández O, Rodríguez-Arellano E et al. Hypertension and lipid triad are the most attributable risks for myocardial infarction in a middle class urban Mexican population. Nutr&Metabol. 2013; 63: 1343.

12. Wong ND, Moran AE. The U.S. prevention of cardiovascular disease guidelines and implications for implementation in LMIC. Glob Heart. 2014; 9: 445-455.

13. Cooney MT, Dudina A, D’Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation. 2010; 122: 300-310.